Well it's safe to say the bears have control of the current sp, however the only thing that is driving this sentiment is lack of updated data and this very low share price. It has been far too long that we have seen positive sentiment on these threads and I assume many of our more optimistic contributors are sitting back waiting for news before returning to fold. The most logical update should be from the Azer-cel trial which should be provided in the next couple of months, given the recent injection of funds. The OASIS trial with the potential to provide hope to 90% of cancers, combining Yuman Fong's wonderful virus with a CD19 targeting CAR-Ts excites many shareholders and proof of concept in human trials is eagerly awaited. Money is in the bank and Leslie Chong will need to be at her most frugal to ensure sufficient funds are available to provide the necessary data to boost our share price. The news that optimal dose is yet to be found is great news as the higher the dose the more proficient it will be in achieving long needed results for patients. Many posters are currently either completely negative on Imugene technology or fatigued investors looking to escape a long bad dream, with updates definitely due in the coming months and the possible but maybe improbable chances of a partner/licensing deal, optimism is a bit low but many possibilities abound.
DYOR opinion only
IMU Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)